January 4, 2024
← back

Mark Your Calendar! PCORI to Announce New Funding Opportunity for PCORnet® Studies

On January 9, PCORI will release the Broad Pragmatic Studies (BPS) PCORI Funding Announcement (PFA) to support high-quality patient-centered comparative clinical effectiveness research (CER). Category 3 supports PCORnet® Studies that advance PCORI’s National Priorities for Health with direct costs of up to $12 million.*

PCORnet® Studies are defined as those that:

  • Include two or more PCORnet-partnered Clinical Research Networks
  • Share study progress and performance metrics
  • Exchange best practices with the Network to promote continuous learning and improvement
  • Demonstrate a commitment to stakeholder engagement and partnership
  • Use PCORnet resources to improve the efficiency of patient-centered CER

Are you ready to learn more and apply? Letters of Intent (LOI) are due February 6. Take these three steps to prepare:

  1. Contact the PCORnet® Front Door as soon as possible. All applicants submitting to the BPS Category 3 PFA are required to contact the PCORnet® Front Door prior to submitting their LOI. The PCORnet® Front Door can advise on study feasibility and costs associated with working with PCORnet, provide data to inform study design, offer best practices for stakeholder engagement, and more.
  2. Register for the January 24 PCORI Applicant Town Hall to learn more about this PFA and how to submit a responsive LOI and application.
  3. Check out this webinar for an overview of PCORnet and the specific requirements for the Category 3: PCORnet® Studies option in the BPS PFA. 

If you are interested in using PCORnet to power your next research effort, now is the time. Be on the lookout for more information from PCORI on January 9.

*Category 3 will support direct costs up to $10 million. However, projects may request to apply for up to $12 million in direct costs with certain justifications and approvals described within the PFA prior to application submission. Funding for innovations to support CER, such as novel approaches to returning results to participants and the use of Fast Healthcare Interoperability Resources (FHIR) technologies to engage, may also be requested in the LOI phase.